Monday, September 13, 2010

Obesity Drugs Thinning as ARNA Collapses ...

All subscribers received an option trade strategy on these obesity drug stocks: Arena Pharmaceuticals (ARNA), Vivus Inc. (VVUS), and Orexigen Therapeutics (OREX).

VVUS has a date with the FDA on September 28th and OREX December 7th.  


9 comments:

  1. I think ARNA will be extended, VVUS looks bleak and OREX not convinced of. Sudeep ")

    ReplyDelete
  2. thanx, cd and brian

    ReplyDelete
  3. nice image fellas, keithster69

    ReplyDelete
  4. That is my thought as well, Q paid 4, thanx. Mo in NJ. and thank you Adam 4 all the work you did for me, FREE 2!

    ReplyDelete
  5. Back after being away for the last qtr. I look forward to your trades- drug stocks- I prefer, DNDN caught my attention first-Dr.Nurel Choudhury-

    ReplyDelete
  6. like arena, but scared abt the fda, sanjaj in ND

    ReplyDelete
  7. Sanj, ARNA failed and now the other ones look good in my eyes. Craig I Am.

    ReplyDelete
  8. made a ton o doe not trading arena that is lower by 37&! OUCH!, glad i sent you the q...nice response, analyst007

    ReplyDelete
  9. POTC you guys rule, end of story. Mike in Miami.

    ReplyDelete

Psychology of the Call